Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction
- PMID: 22241930
- DOI: 10.1192/bjp.bp.111.096479
Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction
Abstract
Background: Depression is a known risk factor for mortality after an acute myocardial infarction. Patients with treatment-responsive depression may have a better prognosis than those with treatment-resistant depression.
Aims: We sought to determine whether mortality following acute myocardial infarction was associated with treatment-resistant depression.
Method: Follow-up began after myocardial infarction and continued until death or censorship. Depression was counted as present if diagnosed any time during the study period. Treatment for depression was defined as receipt of 12 or more weeks of continuous antidepressant therapy at a therapeutic dose during follow-up. Treatment-resistant depression was defined as use of two or more antidepressants plus augmentation therapy, receipt of electroconvulsive therapy or use of monoamine oxidase inhibitors. Mean duration of follow-up was 39 months.
Results: During follow-up of 4037 patients with major depressive disorder who had had a myocardial infarction, 6.9% of those with insufficiently treated depression, 2.4% of those with treated depression and 5.0% of those with treatment-resistant depression died. A multivariable survival model that adjusted for sociodemographics, anxiety disorders, beta-blocker use, mortality risk factors and health service utilisation indicated that compared with treated patients, insufficiently treated patients were 3.04 (95% CI 2.12-4.35) times more likely and patients with treatment-resistant depression were 1.71 (95% CI 1.05-2.79) times more likely to die.
Conclusions: All-cause mortality following an acute myocardial infarction is greatest in patients with depression who are insufficiently treated and is a risk in patients with treatment-resistant depression. However, the risk of mortality associated with treatment-resistant depression is partly explained by comorbid disorders. Further studies are warranted to determine whether changes in depression independently predict all-cause mortality.
Similar articles
-
Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status).Circulation. 2017 May 2;135(18):1681-1689. doi: 10.1161/CIRCULATIONAHA.116.025140. Epub 2017 Feb 16. Circulation. 2017. PMID: 28209727 Free PMC article.
-
Treatment-resistant depression and mortality after acute coronary syndrome.Am J Psychiatry. 2009 Apr;166(4):410-7. doi: 10.1176/appi.ajp.2008.08081239. Epub 2009 Mar 16. Am J Psychiatry. 2009. PMID: 19289455 Free PMC article. Review.
-
Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients.Am J Med. 2011 Apr;124(4):318-24. doi: 10.1016/j.amjmed.2010.11.015. Am J Med. 2011. PMID: 21435422
-
Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial.J Psychosom Res. 2013 Jan;74(1):25-30. doi: 10.1016/j.jpsychores.2012.08.015. Epub 2012 Sep 23. J Psychosom Res. 2013. PMID: 23272985 Clinical Trial.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
-
Changes in treatment outcomes in patients undergoing an integrated psychosomatic inpatient treatment: Results from a cohort study.Front Psychiatry. 2022 Aug 25;13:964879. doi: 10.3389/fpsyt.2022.964879. eCollection 2022. Front Psychiatry. 2022. PMID: 36090361 Free PMC article.
-
Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort study.Lancet Reg Health West Pac. 2022 Mar 15;22:100426. doi: 10.1016/j.lanwpc.2022.100426. eCollection 2022 May. Lancet Reg Health West Pac. 2022. PMID: 35637863 Free PMC article.
-
Association between Estimated Cardiorespiratory Fitness and Depression among Middle-income Country Adults: Evidence from National Health Survey.Clin Pract Epidemiol Ment Health. 2021 Dec 22;17:198-204. doi: 10.2174/1745017902117010198. eCollection 2021. Clin Pract Epidemiol Ment Health. 2021. PMID: 35173788 Free PMC article.
-
Psychological and pharmacological interventions for depression in patients with coronary artery disease.Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4. Cochrane Database Syst Rev. 2021. PMID: 34910821 Free PMC article. Review.
-
Novel drug developmental strategies for treatment-resistant depression.Br J Pharmacol. 2022 Mar;179(6):1146-1186. doi: 10.1111/bph.15753. Epub 2022 Jan 26. Br J Pharmacol. 2022. PMID: 34822719 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
